Yi JinSenior Director of Research & Discovery at GenScript ProBio
Dr. Yi Jin obtained her Ph.D. degree from Iowa State University and received postdoc training at University of California at Berkeley later. She has 13 years experience on therapeutic biologics discovery and development. Worked as project leaders for antibody discovery at Bayer (USA), responsible for antibody discovery and novel technology platform. During her tenure, she led multiple projects through different stages of the development, including target discovery and validation on autoimmune disease and cancer immunotherapy. Currently, she serves as the senior director of Research and discovery in Biological Drug Business Unit at Genscript.